Sitagliptin (Standard)

CAT: 0804-HY-13749R-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0804-HY-13749R-01Size:10 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Sitagliptin (Standard) is the analytical standard of Sitagliptin (HY-13749) . This product is intended for research and analytical applications. Sitagliptin is an orally active and highly selective DPP4 inhibitor with an IC50 value of 19 nM. Sitagliptin blocks the degradation of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) by competing inhibition mechanism (Kᵢ = 1 nM), thereby increasing the level of active incretin. Sitagliptin can also directly stimulate the secretion of GLP-1 by intestinal L cells by activating the cAMP/PKA and ERK1/2 pathways, and this effect is independent of DPP-4. Sitagliptin shows protective effects on pancreatic islet grafts in 1-type diabetes models. Sitagliptin can be used for the study of 1-type and 2-type diabetes.
CAS Number
[486460-32-6]
Product Name Alternative
MK-0431 (Standard)
UNSPSC
12352100
Target
Dipeptidyl Peptidase; Endogenous Metabolite; ERK; GLP Receptor; PKA; Reference Standards
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Others; Stem Cell/Wnt; TGF-beta/Smad
Field of Research
Metabolic Disease
Smiles
O=C(N1CC2=NN=C(C(F)(F)F)N2CC1)C[C@H](N)CC3=CC(F)=C(F)C=C3F
Molecular Formula
C16H15F6N5O
Molecular Weight
407.31
References & Citations
[1]Thomas, L., et al. (R) -8- (3-amino-piperidin-1-yl) -7-but-2-ynyl-3-methyl-1- (4-methyl-quinazolin-2-ylmethyl) -3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors. J Pharmacol Exp Ther. 2008 Apr;325 (1) :175-82.|[2]Kim, S.J., et al., Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation. Diabetes, 2009. 58 (3) : p. 641-51.|[3]Sangle, G.V., et al., Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a GLP-1 secretagogue. Endocrinology, 2012. 153 (2) : p. 564-73.|[4]Kim, S.J., et al., Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Diabetes, 2008. 57 (5) : p. 1331-9.|[5]Beconi, M.G., et al. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs. Drug Metab Dispos, 2007. 35 (4) : p. 525-32.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Clinical Information
Launched

Related Products

CatalogName
HY-13749AR-01Sitagliptin (phosphate) (Standard)
HY-Z4409RSitagliptin impurity 6 (Standard)
HY-13749CR(S) -Sitagliptin (phosphate) (Standard)
HY-Z0357RSitagliptin impurity 5 (Standard)
HY-Z2765RSitagliptin impurity 4 (Standard)
HY-13749BR-01Sitagliptin (phosphate monohydrate) (Standard)
HY-13749-01Sitagliptin
HY-13749S3Sitagliptin-d6
HY-13749ESitagliptin (hydrochloride)
HY-13749A-01Sitagliptin (phosphate)

Alternative Products

CatalogName
RM-S200770-01Sitagliptin
MBS3616294-01Sitagliptin phosphate
TYD-02661-01(Rac) -Sitagliptin
MBS6073879-01rac-Sitagliptin
TRC-D290555-250MGDesfluoro Sitagliptin

Popular Products